Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2014. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2014. Go to the latest filing (Q3 2026)

22.9B USDQ2 2014
Total value of stock positions
22.9B USD
Positions
62
Share of the ten largest
48.1%

The ten largest positions Q2 2014

  1. Walgreen Co 6.5%▼ −16.5%
  2. Valeant Pharmaceuticals Intl 6.5%▲ +27.3%
  3. Illumina, Inc. 6.2%▼ −9.9%
  4. Lowe's 4.8%▲ +26.5%
  5. LyondellBasell 4.6%▼ −16.2%
  6. Thermo Fisher Scientific 4.3%▼ −14.5%
  7. Pioneer Nat Res Co 4.1%▲ +148.7%
  8. Baidu (ADR) 3.8%▲ +10.4%
  9. Capital One 3.7%▼ −6.7%
  10. Regeneron Pharmaceuticals 3.7%▲ +181.8%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q2 2014

Positions Q2 2014 per 13F filing, 62 of 62
Symbol Weight Shares Reported value Change Held since
Valeant Pharmaceuticals Intl 6.5% 11,830,932 1.5B USD +27.3% increased Q2 2013 or earlier 5 quarters
LYB LyondellBasell 4.6% 10,771,736 1.1B USD −16.2% reduced Q2 2013 or earlier 5 quarters
TMO Thermo Fisher Scientific 4.3% 8,271,280 976.0M USD −14.5% reduced Q2 2013 or earlier 5 quarters
COF Capital One 3.7% 10,165,787 839.7M USD −6.7% reduced Q2 2013 or earlier 5 quarters
MA Mastercard 3.1% 9,820,830 721.5M USD +27.0% increased Q2 2013 or earlier 5 quarters
Monsanto Co New 3.1% 5,780,631 721.1M USD +86.6% increased Q2 2013 or earlier 5 quarters
MU Micron Technology 2.5% 17,699,068 583.2M USD −14.4% reduced Q2 2013 or earlier 5 quarters
V Visa Inc. 2.5% 2,744,653 578.3M USD 0.0% reduced Q2 2013 or earlier 5 quarters
Time Warner Inc 2.4% 7,872,453 553.0M USD −63.6% reduced Q2 2013 or earlier 5 quarters
Alexion Pharmaceuticals Inc 1.4% 2,006,092 313.5M USD +9.2% increased Q2 2013 or earlier 5 quarters
Michael Kors HLDGS Ltd 1.0% 2,658,573 235.7M USD −60.1% reduced Q2 2013 or earlier 5 quarters
VLO Valero Energy 0.9% 4,218,837 211.4M USD −65.2% reduced Q2 2013 or earlier 5 quarters
Block H & R Inc 0.9% 6,133,995 199.8M USD −64.0% reduced Q2 2013 or earlier 5 quarters
UHS Universal Health Services 0.5% 1,277,443 122.3M USD −53.7% reduced Q2 2013 or earlier 5 quarters
Crown Castle Intl Corp 0.3% 918,640 68.2M USD −64.3% reduced Q2 2013 or earlier 5 quarters
Triumph Group Inc New 0.3% 956,398 66.8M USD −74.2% reduced Q2 2013 or earlier 5 quarters
ADBE Adobe Inc. 0.2% 685,000 49.6M USD −72.3% reduced Q2 2013 or earlier 5 quarters
LOW Lowe's 4.8% 22,907,968 1.1B USD +26.5% increased Q3 2013 4 quarters
BIDU Baidu (ADR) 3.8% 4,681,428 874.5M USD +10.4% increased Q3 2013 4 quarters
Twenty First Centy Fox Inc 2.0% 13,229,932 465.0M USD −65.1% reduced Q3 2013 4 quarters
Cameron International Corp 1.4% 4,889,535 331.1M USD −37.4% reduced Q3 2013 4 quarters
STZ Constellation Brands 1.3% 3,308,832 291.6M USD −52.8% reduced Q3 2013 4 quarters
META Meta Platforms 1.2% 4,087,288 275.0M USD −53.7% reduced Q3 2013 4 quarters
Blackberry Ltd 0.2% 3,888,791 39.8M USD unchanged Q3 2013 4 quarters
Walgreen Co 6.5% 20,137,154 1.5B USD −16.5% reduced Q4 2013 3 quarters
ILMN Illumina, Inc. 6.2% 7,992,844 1.4B USD −9.9% reduced Q4 2013 3 quarters
Mohawk Inds Inc 2.7% 4,543,823 628.6M USD +80.8% increased Q4 2013 3 quarters
MDLZ Mondelez International 2.6% 15,898,877 598.0M USD +3.8% increased Q4 2013 3 quarters
Canadian Pac Ry Ltd 2.4% 3,004,242 544.2M USD −25.3% reduced Q4 2013 3 quarters
Actavis PLC 1.2% 1,207,824 269.4M USD +10.7% increased Q4 2013 3 quarters
DVA DaVita 1.1% 3,489,084 252.3M USD +82.0% increased Q4 2013 3 quarters
Acadia Pharmaceuticals Inc 0.5% 4,757,878 107.5M USD +32.2% increased Q4 2013 3 quarters
Concho Res Inc < 0.1% 17,370 2.5M USD −99.3% reduced Q4 2013 3 quarters
Pioneer Nat Res Co 4.1% 4,072,836 936.0M USD +148.7% increased Q1 2014 2 quarters
REGN Regeneron Pharmaceuticals 3.7% 2,963,456 837.1M USD +181.8% increased Q1 2014 2 quarters
Salix Pharmaceuticals Inc 1.6% 2,889,303 356.4M USD +86.2% increased Q1 2014 2 quarters
Kansas City Southern 1.4% 3,027,831 325.5M USD +64.8% increased Q1 2014 2 quarters
WDAY Workday, Inc. 0.9% 2,271,588 204.1M USD −27.3% reduced Q1 2014 2 quarters
ADSK Autodesk 0.6% 2,238,794 126.2M USD −60.9% reduced Q1 2014 2 quarters
Zynga Inc 0.4% 25,926,695 83.2M USD −8.9% reduced Q1 2014 2 quarters
Intercept Pharmaceuticals In 0.2% 208,077 49.2M USD −54.3% reduced Q1 2014 2 quarters
STT State Street Corporation 0.2% 596,894 40.1M USD +3.6% increased Q1 2014 2 quarters
NFLX Netflix 2.5% 1,317,517 580.5M USD new Q2 2014 1 quarter
Newfield Expl Co 1.0% 5,364,990 237.1M USD new Q2 2014 1 quarter
AAPL Apple Inc. 0.9% 2,286,178 212.5M USD new Q2 2014 1 quarter
CTSH Cognizant 0.8% 3,915,440 191.5M USD new Q2 2014 1 quarter
HLT Hilton Worldwide 0.8% 7,681,424 179.0M USD new Q2 2014 1 quarter
RL Ralph Lauren Corporation 0.7% 1,048,443 168.5M USD new Q2 2014 1 quarter
Allergan Inc 0.6% 803,369 135.9M USD new Q2 2014 1 quarter
Wellpoint Inc 0.4% 954,285 102.7M USD new Q2 2014 1 quarter
Rite Aid Corp 0.4% 13,458,963 96.5M USD new Q2 2014 1 quarter
Precision Castparts Corp 0.4% 328,801 83.0M USD new Q2 2014 1 quarter
Ctrip Com Intl Ltd 0.3% 1,178,463 75.5M USD new Q2 2014 1 quarter
Cimarex Energy Co 0.3% 498,700 71.5M USD new Q2 2014 1 quarter
ZBH Zimmer Biomet 0.3% 603,193 62.6M USD new Q2 2014 1 quarter
PFG Principal Financial Group 0.3% 1,142,537 57.7M USD new Q2 2014 1 quarter
Melco Crown Entmt Ltd 0.2% 1,541,269 55.0M USD new Q2 2014 1 quarter
CNC Centene Corporation 0.2% 708,677 53.6M USD new Q2 2014 1 quarter
Myriad Genetics Inc 0.2% 1,330,294 51.8M USD new Q2 2014 1 quarter
American Airls Group Inc < 0.1% 509,600 21.9M USD new Q2 2014 1 quarter
SBAC SBA Communications < 0.1% 149,697 15.3M USD new Q2 2014 1 quarter
ALLE Allegion < 0.1% 234,242 13.3M USD new Q2 2014 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Health Care 16.3%
  • Financials 9.8%
  • Consumer Discretionary 6.3%
  • Technology 6.0%
  • Materials 4.6%
  • Consumer Staples 3.9%
  • Communication Services 3.7%
  • Energy 0.9%
  • Real Estate < 0.1%
  • Industrials < 0.1%
  • not in our coverage 48.4%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close